103
Views
7
CrossRef citations to date
0
Altmetric
Original Research

miR-21-5p is a Biomarker for Predicting Prognosis of Lung Adenocarcinoma by Regulating PIK3R1 Expression

ORCID Icon, , , , &
Pages 8873-8880 | Published online: 25 Nov 2021

References

  • Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics [published correction appears in CA Cancer J Clin. 2011 Mar-Apr;61(2):134]. CA Cancer J Clin. 2011;61(2):69–90. doi:10.3322/caac.20107
  • Chen C, Liu X, Chen C, Chen Q, Dong Y, Hou B. Clinical significance of let-7a-5p and miR-21-5p in patients with breast cancer. Ann Clin Lab Sci. 2019;49(3):302–308.
  • Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.21338
  • Zarogoulidis K, Zarogoulidis P, Darwiche K, et al. Treatment of non-small cell lung cancer (NSCLC). J Thorac Dis. 2013;5 Suppl 4(Suppl4):S389–S396. doi:10.3978/j.issn.2072-1439.2013.07.10
  • Daugaard I, Knudsen A, Kjeldsen TE, Hager H, Hansen LL. The association between miR-34 dysregulation and distant metastases formation in lung adenocarcinoma. Exp Mol Pathol. 2017;102(3):484–491. doi:10.1016/j.yexmp.2017.05.012
  • Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–E386. doi:10.1002/ijc.29210
  • Fu HL, Wu DP, Wang XF, et al. Altered miRNA expression is associated with differentiation, invasion, and metastasis of esophageal squamous cell carcinoma (ESCC) in patients from Huaian, China. Cell Biochem Biophys. 2013;67(2):657–668. doi:10.1007/s12013-013-9554-3
  • Han Q, Lin X, Zhang X, et al. WWC3 regulates the Wnt and Hippo pathways via Dishevelled proteins and large tumour suppressor 1, to suppress lung cancer invasion and metastasis. J Pathol. 2017;242(4):435–447. doi:10.1002/path.4919
  • Yuan B, Yu WY, Dai LS, et al. Expression of microRNA-26b and identification of its target gene EphA2 in pituitary tissues in Yanbian cattle. Mol Med Rep. 2015;12(4):5753–5761. doi:10.3892/mmr.2015.4192
  • Hermann A, Wennmann DO, Gromnitza S, et al. WW and C2 domain-containing proteins regulate hepatic cell differentiation and tumorigenesis through the hippo signaling pathway. Hepatology. 2018;67(4):1546–1559. doi:10.1002/hep.29647
  • Kao HW, Pan CY, Lai CH, et al. Urine miR-21-5p as a potential non-invasive biomarker for gastric cancer. Oncotarget. 2017;8(34):56389–56397. doi:10.18632/oncotarget.16916
  • Tang J, Li X, Cheng T, Wu J. miR-21-5p/SMAD7 axis promotes the progress of lung cancer [published online ahead of print, 2021 Jul 12]. Thorac Cancer. 2021;12(17):2307–2313. doi:10.1111/1759-7714.14060
  • Li T, Li D, Sha J, Sun P, Huang Y. MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells. Biochem Biophys Res Commun. 2009;383(3):280–285. doi:10.1016/j.bbrc.2009.03.077
  • Kumar S, Keerthana R, Pazhanimuthu A, Perumal P. Overexpression of circulating miRNA-21 and miRNA-146a in plasma samples of breast cancer patients. Indian J Biochem Biophys. 2013;50(3):210–214.
  • Li BS, Zhao YL, Guo G, et al. Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection. PLoS One. 2012;7(7):e41629. doi:10.1371/journal.pone.0041629
  • Tao L, Wu YQ, Zhang SP. MiR-21-5p enhances the progression and paclitaxel resistance in drug-resistant breast cancer cell lines by targeting PDCD4. Neoplasma. 2019;66(5):746–755. doi:10.4149/neo_2018_181207N930
  • Jin XH, Lu S, Wang AF. Expression and clinical significance of miR-4516 and miR-21-5p in serum of patients with colorectal cancer. BMC Cancer. 2020;20(1):241. doi:10.1186/s12885-020-06715-6
  • Wang G, Zhou Y, Chen W, et al. miR-21-5p promotes lung adenocarcinoma cell proliferation, migration and invasion via targeting WWC2. Cancer Biomark. 2020;28(4):549–559. doi:10.3233/CBM-201489
  • Merrick DT, Kittelson J, Winterhalder R, et al. Analysis of c-ErbB1/epidermal growth factor receptor and c-ErbB2/HER-2 expression in bronchial dysplasia: evaluation of potential targets for chemoprevention of lung cancer. Clin Cancer Res. 2006;12(7 Pt 1):2281–2288. doi:10.1158/1078-0432.CCR-05-2291
  • Liu Z, Yu M, Fei B, Fang X, Ma T, Wang D. miR‑21‑5p targets PDHA1 to regulate glycolysis and cancer progression in gastric cancer. Oncol Rep. 2018;40(5):2955–2963. doi:10.3892/or.2018.6695
  • Zhu T, Yu Y, Liu J, Ren K. Identification of a competing endogenous RNA network related to immune signature in lung adenocarcinoma. Front Genet. 2021;12:665555. doi:10.3389/fgene.2021.665555
  • Yuan TL, Cantley LC. PI3K pathway alterations in cancer: variations on a theme. Oncogene. 2008;27(41):5497–5510. doi:10.1038/onc.2008.245